RLAY: relaytx.com Net earnings per share for the last 12 months

Symbol and logo of brand Relay Therapeutics, Inc. (RLAY)

The reliability of Relay Therapeutics (RLAY) is based on its partnership with Roche and the monetization of the Dynamite AI system. The annual EPS TTM snapshot clearly confirms this stability, where the value -1.52 serves as the baseline metric. The efficiency of digital drug design and the diversification of clinical programs through IT protein modeling create additional benchmarks for long-term investment in precision oncology.

RLAY (Relay Therapeutics) Net earnings per share (EPS TTM) history from 07/04/2022 to 11/12/2026

Analytical breakdowns for Relay Therapeutics

- share price and expert price forecast:
Stock Quotes Relay Therapeutics|RLAY - Fair Value Consensus
- market capitalization information:
Market Valuation Relay Therapeutics, Inc.|RLAY - Aggregate Business Value
- balance sheet net asset value indicators:
Book Value per Share Relay Therapeutics|RLAY - Book Capitalization|Market Value to Book Value Ratio relaytx.com|RLAY - Aggregate Asset Value
- business debt structure and liquidity details:
Total Debt to Capital Relay Therapeutics|RLAY - Long-Term Indebtedness to Equity|Short-Term Debt to Capital Relay Pharma|RLAY - Company Cumulative Debt|Debt to Book Value Relay Therapeutics, Inc.|RLAY - Amount of Long-Term Liabilities|Company Short-Term Debts Relay Therapeutics|Quick Ratio relaytx.com
- net income and valuation multiples indicators:
RLAY - Company Profit|Future Profit Relay Therapeutics|RLAY - Company Value to Net Income|Projected Price to Earnings Relay Therapeutics, Inc.|RLAY - Company Value to Earnings Growth Ratio|EV/EBITDA Multiple Relay Therapeutics, Inc.|RLAY - Income before deduction of interest, taxes and amortization|Net earnings per share (EPS TTM) Relay Therapeutics|RLAY - Net earnings per one share for the last twelve months|Year-over-year earnings per share growth for the last twelve months relaytx.com|RLAY - Earnings per share increase in current year|Earnings growth forecast for next year Relay Therapeutics
Basic company analysis:Relay Therapeutics - RLAY
Manufactured products of Relay Therapeutics Inc

The development of targeted therapies for rare cancers makes the survival of Relay Therapeutics (RLAY) dependent on FDA verdicts, which directly impacts its financial stability. By analyzing the 12-month earnings per share history, an investor assesses the real return per share, adjusted for equity dilution, to determine the business's margin of safety amid expensive borrowing and liquidity freeze risks.

Who Relay Therapeutics competes with

GMAB: Net earnings per share for the last 12 months|Earnings per share for the trailing year EXEL (exelixis.com)|NUVL (Nuvalent) - Net earnings per share for the last 12 months|KYMR: Earnings per share for the last four quarters|IDYA (IDEAYA Bio) - Net earnings per share (EPS TTM)|Net earnings per share (EPS TTM) Enliven Corp|Earnings per share for the last twelve months ORIC Pharmaceuticals (ORIC)|NRIX (nurixtx.com) - Earnings per share for the trailing year|Net earnings per share (EPS TTM) TYRA (Tyra Biosciences)|Net earnings per share for the trailing year Verastem Oncology|Monte Rosa Tx - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Cullinan Corp|IMRX (Immuneering Corporation) - Net earnings per share for the last 12 months|CCCC: Earnings per share for the last four quarters|BDTX (Black Diamond Therapeutics) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Repare Therapeutics, Inc. RPTX|Net earnings per share (EPS TTM) PMVP|karyopharm.com - Earnings per share for the last 12 months|Propanc Biopharma - Net earnings per share for the last 12 months|Earnings per share for the trailing year BGMS|AADI: Net earnings per share for the last 12 months|Aileron Therapeutics - Earnings per share for the last four quarters|BPMC: Net earnings per share (EPS TTM)|GlycoMimetics - Earnings per share for the trailing year|SWTX (SpringWorks Therapeutics) - Net earnings per share (EPS TTM)